29 related articles for article (PubMed ID: 8439517)
1. Guava (
Ruksiriwanich W; Khantham C; Muangsanguan A; Phimolsiripol Y; Barba FJ; Sringarm K; Rachtanapun P; Jantanasakulwong K; Jantrawut P; Chittasupho C; Chutoprapat R; Boonpisuttinant K; Sommano SR
Plants (Basel); 2022 Dec; 11(24):. PubMed ID: 36559626
[TBL] [Abstract][Full Text] [Related]
2. The human keratinocyte cell line HaCaT: an in vitro cell culture model for keratinocyte testosterone metabolism.
Altenburger R; Kissel T
Pharm Res; 1999 May; 16(5):766-71. PubMed ID: 10350023
[No Abstract] [Full Text] [Related]
3. Finasteride: a review of its use in male pattern hair loss.
McClellan KJ; Markham A
Drugs; 1999 Jan; 57(1):111-26. PubMed ID: 9951956
[TBL] [Abstract][Full Text] [Related]
4. Effect of finasteride in idiopathic hirsutism.
Faloia E; Filipponi S; Mancini V; Di Marco S; Mantero F
J Endocrinol Invest; 1998 Nov; 21(10):694-8. PubMed ID: 9854686
[TBL] [Abstract][Full Text] [Related]
5. Synthesis and in vitro activity of 17 beta-(N-alkyl/arylformamido)- and 17 beta-[(N-alkyl/aryl)alkyl/arylamido]-4-methyl-4-aza-3-oxo-5 alpha-androstan-3-ones as inhibitors of human 5 alpha-reductases and antagonists of the androgen receptor.
Li X; Singh SM; Labrie F
J Med Chem; 1995 Mar; 38(7):1158-73. PubMed ID: 7707319
[TBL] [Abstract][Full Text] [Related]
6. Human osteoblast-like cells express predominantly steroid 5alpha-reductase type 1.
Issa S; Schnabel D; Feix M; Wolf L; Schaefer HE; Russell DW; Schweikert HU
J Clin Endocrinol Metab; 2002 Dec; 87(12):5401-7. PubMed ID: 12466325
[TBL] [Abstract][Full Text] [Related]
7. 4-Azasteroidal 5 alpha-reductase inhibitors without affinity for the androgen receptor.
Liang T; Heiss CE; Cheung AH; Reynolds GF; Rasmusson GH
J Biol Chem; 1984 Jan; 259(2):734-9. PubMed ID: 6693392
[TBL] [Abstract][Full Text] [Related]
8. Inhibition of 5 alpha-reductase activity and alteration of nuclear testosterone. Dihydrotestosterone ratio in human genital skin fibroblasts.
Berkovitz GD; Brown TR; Migeon CJ
J Androl; 1984; 5(3):171-5. PubMed ID: 6746410
[TBL] [Abstract][Full Text] [Related]
9. 4-Methyl-3-oxo-4-aza-5alpha-androst-1-ene-17beta-N-aryl-carboxamides: an approach to combined androgen blockade [5alpha-reductase inhibition with androgen receptor binding in vitro].
Tolman RL; Sahoo SP; Bakshi RK; Gratale D; Patel G; Patel S; Toney J; Chang B; Harris GS
J Steroid Biochem Mol Biol; 1997 Mar; 60(5-6):303-9. PubMed ID: 9219921
[TBL] [Abstract][Full Text] [Related]
10. Azasteroids as inhibitors of testosterone 5 alpha-reductase in mammalian skin.
Mellin TN; Busch RD; Rasmusson GH
J Steroid Biochem Mol Biol; 1993 Feb; 44(2):121-31. PubMed ID: 8439517
[TBL] [Abstract][Full Text] [Related]
11. The enzyme and inhibitors of 4-ene-3-oxosteroid 5 alpha-oxidoreductase.
Li X; Chen C; Singh SM; Labrie F; Labire F [corrected to Labrie F]
Steroids; 1995 Jun; 60(6):430-41. PubMed ID: 7676475
[TBL] [Abstract][Full Text] [Related]
12. The clinical development of a 5 alpha-reductase inhibitor, finasteride.
Stoner E
J Steroid Biochem Mol Biol; 1990 Nov; 37(3):375-8. PubMed ID: 1701660
[TBL] [Abstract][Full Text] [Related]
13.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
14.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]